Immunoresponse to Wilms Tumor antigen-1 (WT-1) in CML patients.
Glavni autori: | Bellantuono, I, Macchiarulo, E, Gao, L, Dazzi, F, Cerundolo, V, Marley, S, Gordon, M, Goldman, J, Stauss, H |
---|---|
Format: | Journal article |
Izdano: |
2000
|
Slični predmeti
-
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency
od: Lahman, MC, i dr.
Izdano: (2022) -
Transcription factor Wilms' tumor 1 regulates developmental RNAs through 3' UTR interaction.
od: Bharathavikru, R, i dr.
Izdano: (2017) -
Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen.
od: Savage, P, i dr.
Izdano: (2004) -
WT1 mutations in T-ALL.
od: Tosello, V, i dr.
Izdano: (2009) -
Tumor Wilms yang disertai sindroma Cushing - Suatu laporan kasus.
od: Perpustakaan UGM, i-lib
Izdano: (1997)